BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

MANNITOL injection, solution Estats Units - anglès - NLM (National Library of Medicine)

mannitol injection, solution

hospira, inc. - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol intravenous (mannitol injection, usp) is indicated for the following purposes in adults and pediatric patients. - reduction of intracranial pressure and brain mass. - reduction of high intraocular pressure when the pressure cannot be lowered by other means. measurement of glomerular filtration rate. - well established anuria due to severe renal disease. - severe pulmonary congestion or frank pulmonary edema. - active intracranial bleeding except during craniotomy. - severe dehydration. - progressive heart failure or pulmonary congestion after institution of mannitol therapy. - do not administer to patients with a known hypersensitivity to mannitol. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will dimin

Polyfusor mannitol 20% infusion 500ml bottles Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

polyfusor mannitol 20% infusion 500ml bottles

fresenius kabi ltd - mannitol - infusion - 200mg/1ml

OSMITROL Mannitol 100g/500mL injection AHB3025 Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

osmitrol mannitol 100g/500ml injection ahb3025

baxter healthcare pty ltd - mannitol, quantity: 200 g/l - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.

Mannitol 50g/250ml (20%) infusion Viaflex bags Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

mannitol 50g/250ml (20%) infusion viaflex bags

20%) infusion viaflex bags (baxter healthcare ltd - mannitol - infusion - 200mg/1ml

POTASSIUM CHLORIDE 20 mmol in SODIUM CHLORIDE 0.9% 500 mL injection for intravenous infusion bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 3 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 10 mmol in SODIUM CHLORIDE 0.9% 500 mL injection for intravenous infusion bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

potassium chloride 10 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 20 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 40 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

potassium chloride 40 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 3 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia